To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer
Clinical trial NCT03215264 · COMPLETED
Trial details
- NCT number
- NCT03215264
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-02
- Primary completion
- 2020-06-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.